To study mean platelet volume-platelet count ratio in assessing severity in COVID-19 patients
Author(s): Dr. Deepshikha Bhalse, Dr. Dolly Joseph and Dr. RK Jha
Aim and Objectives: The association between platelet mean volume/platelet count ratio (MPR) and new coronavirus infectious disease 2019 (COVID-19) is not completely understood despite the fact that MPR is often regarded as an important marker of inflammatory and infectious disorders.
Materials and Method: COVID-19 RTPCR Positive patients (male and female) seeking medical attention at SAIMS during the period ofFebruary-April 2021 was included. Patients who were less than 18 years old or who suffered from liver disorders were not allowed to participate in this study. The Ethics Committee gave its clearance to this prospective- retrospective study using a cohort.
Results: The Mean Platelet Ratio can be used as an indicator for severity in COVID-19 patients.
Conclusion: Patients diagnosed with COVID-19 who have a high MPR level are at an increased risk for developing severe pneumonia.
Dr. Deepshikha Bhalse, Dr. Dolly Joseph, Dr. RK Jha. To study mean platelet volume-platelet count ratio in assessing severity in COVID-19 patients. Int J Adv Res Med 2023;5(1):94-97. DOI: 10.22271/27069567.2023.v5.i1b.455